ATHE

1.5208.16%
IS

Ira Shoulson

Chairman of Research & Development Advisory Board

Dr. Ira Shoulson, M.D. serves as Chairman of Research & Development Advisory Board at Alterity Therapeutics Limited. Dr. Shoulson serves as Louis C. Lasagna Professor of Experimental Therapeutics and Professor of Neurology, Pharmacology and Medicine at the University of Rochester School of Medicine & Dentistry in Rochester, New York. Dr. Shoulson serves as Member of Scientific Advisory Board at Link Medicine Corporation. He served as a Non-Executive Director at Alterity Therapeutics Limited (formerly, Prana Biotechnology Limited) since May 13, 2014 until April 8, 2019. Dr. Shoulson is Professor of Neurology, Pharmacology and Human Science at Georgetown University, Washington, DC, USA and Director of the University's Program for Regulatory Science and Medicine (PRSM). He is also principal investigator of the Georgetown University Center of Excellence in Regulatory Science and Innovation (CERSI), one of four research and education centers funded by the Food and Drug Administration (FDA).

Positions